SAB Biotherapeutics, Inc.
Hedge Funds Holdings

Last updated:

SAB Biotherapeutics, Inc.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 0.43% of the total amount of its stocks outstanding. This makes up a total of 183.28K shares of SAB Biotherapeutics, Inc.. Compared to the previous quarter, the number fell by -89.22% or -1.51M shares fewer. As for the holding position changes, 20% (1) of current holders sold a part of the shares held. 1 hedge funds are new holders of SAB Biotherapeutics, Inc. stock in Q1 2023, it is 20% of total holders.

Hedge funds holding SAB Biotherapeutics (Q4 2021 – Q1 2023)

Number of hedge funds
Q4 2021 21
Q1 2022 12
Q2 2022 13
Q3 2022 13
Q4 2022 11
Q1 2023 5

Hedge funds changes in SAB Biotherapeutics positions (Q4 2021 – Q1 2023)

Changes in positions
Q4 2021 210000
Q1 2022 0259-4
Q2 2022 11506
Q3 2022 12415
Q4 2022 14132
Q1 2023 10103

Hedge funds changes in SAB Biotherapeutics stock options (Q4 2021 – Q1 2023)

Changes in stock options
Q4 2021 2,338,000 0
Q1 2022 1,103,000 0
Q2 2022 425,000 0
Q3 2022 177,000 0
Q4 2022 3,000 0
Q1 2023 0 0

Top 50 hedge fund holders of SAB Biotherapeutics, Inc. (NASDAQ:SABSW)

Hedge fund Value Shares owned Portfolio share
LMR PARTNERS LLP 272K 387.58K 0.005%
MARSHALL WACE, LLP Paul Marshall 173K 247.57K 0.000%
SHAOLIN CAPITAL MANAGEMENT LLC 41K 662.69K 0.001%
RADCLIFFE CAPITAL MANAGEMENT, L.P. 27K 38.92K 0.001%
BALYASNY ASSET MANAGEMENT L.P. Dmitry Balyasny 18K 281.10K 0.000%
MORGAN STANLEY 9K 146.43K 0.000%
YAKIRA CAPITAL MANAGEMENT, INC. 7K 108.48K 0.001%
MILLENNIUM MANAGEMENT LLC Israel Englander 4K 62.5K 0.000%
EQUITEC PROPRIETARY MARKETS, LLC 3K 45K 0.001%
WALLEYE CAPITAL LLC 1K 23.25K 0.000%
HRT FINANCIAL LP 1K 23.75K 0.000%
WALLEYE TRADING LLC 1K 15.50K 0.000%
FLOW TRADERS U.S. LLC 1K 11.73K 0.000%
CITADEL ADVISORS LLC Ken Griffin 1K 19.90K 0.000%
JANE STREET GROUP, LLC 1K 10.48K 0.000%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0 0 0.000%